Crossmark

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

Crossref DOI link: https://doi.org/10.1136/annrheumdis-2013-204948

Published Print: 2015-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Buch, Maya H

Silva-Fernandez, Lucia

Carmona, Loreto

Aletaha, Daniel

Christensen, Robin

Combe, Bernard

Emery, Paul

Ferraccioli, Gianfranco

Guillemin, Francis

Kvien, Tore K

Landewe, Robert

Pavelka, Karel

Saag, Kenneth

Smolen, Josef S

Symmons, Deborah

van der Heijde, Désirée

Welling, Joep

Wells, George

Westhovens, Rene

Zink, Angela

Boers, Maarten
License Information

Text and Data Mining valid from 2015-06-01

Text and Data Mining valid from 2015-06-01

Version of Record valid from 2014-05-14
More Information

This article is maintained by: Elsevier

Article Title: Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

Journal Title: Annals of the Rheumatic Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1136/annrheumdis-2013-204948

Content Type: article

Copyright: Copyright © 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.